Home Pharmaceuticals SGLT2 Inhibitors Market Size, Top Share, Demand | Industry Report, 2034

SGLT2 Inhibitors Market Size & Outlook, 2026-2034

SGLT2 Inhibitors Market Size, Share & Trends Analysis Report By Drug (Canagliflozin, Dapagliflozin, Empagliflozin, Ertugliflozin, Ipragliflozin, Sotagliflozin, Others), By Indication (Type 2 Diabetes, Cardiovascular, Chronic Kidney Disease, Weight Management, Others), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, Online Pharmacies) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Report Code: SRPH57974DR
Last Updated : Dec, 2025
Pages : 110
Author : Debashree Bora
Format : PDF, Excel

Market Segmentation

  1. SGLT2 Inhibitors Market, By Drug (2022-2034)
    1. Canagliflozin
    2. Dapagliflozin
    3. Empagliflozin
    4. Ertugliflozin
    5. Ipragliflozin
    6. Sotagliflozin
    7. Others
  2. SGLT2 Inhibitors Market, By Indication (2022-2034)
    1. Type 2 Diabetes
    2. Cardiovascular
    3. Chronic Kidney Disease 
    4. Weight Management
    5. Others
  3. SGLT2 Inhibitors Market, By Distribution Channel (2022-2034)
    1. Hospital Pharmacies
    2. Drug Stores & Retail Pharmacies
    3. Online Pharmacies
    1. North America
      1. North America SGLT2 Inhibitors Market, By Drug
        1. Canagliflozin
          1. Dapagliflozin
            1. Empagliflozin
              1. Ertugliflozin
                1. Ipragliflozin
                  1. Sotagliflozin
                    1. Others
                    2. North America SGLT2 Inhibitors Market, By Indication
                      1. Type 2 Diabetes
                        1. Cardiovascular
                          1. Chronic Kidney Disease 
                            1. Weight Management
                              1. Others
                              2. North America SGLT2 Inhibitors Market, By Distribution Channel
                                1. Hospital Pharmacies
                                  1. Drug Stores & Retail Pharmacies
                                    1. Online Pharmacies
                                    2. U.S.
                                      1. U.S. SGLT2 Inhibitors Market, By Drug
                                        1. Canagliflozin
                                          1. Dapagliflozin
                                            1. Empagliflozin
                                              1. Ertugliflozin
                                                1. Ipragliflozin
                                                  1. Sotagliflozin
                                                    1. Others
                                                    2. U.S. SGLT2 Inhibitors Market, By Indication
                                                      1. Type 2 Diabetes
                                                        1. Cardiovascular
                                                          1. Chronic Kidney Disease 
                                                            1. Weight Management
                                                              1. Others
                                                              2. U.S. SGLT2 Inhibitors Market, By Distribution Channel
                                                                1. Hospital Pharmacies
                                                                  1. Drug Stores & Retail Pharmacies
                                                                    1. Online Pharmacies
                                                                  2. Canada
                                                                2. Europe
                                                                  1. Europe SGLT2 Inhibitors Market, By Drug
                                                                    1. Canagliflozin
                                                                      1. Dapagliflozin
                                                                        1. Empagliflozin
                                                                          1. Ertugliflozin
                                                                            1. Ipragliflozin
                                                                              1. Sotagliflozin
                                                                                1. Others
                                                                                2. Europe SGLT2 Inhibitors Market, By Indication
                                                                                  1. Type 2 Diabetes
                                                                                    1. Cardiovascular
                                                                                      1. Chronic Kidney Disease 
                                                                                        1. Weight Management
                                                                                          1. Others
                                                                                          2. Europe SGLT2 Inhibitors Market, By Distribution Channel
                                                                                            1. Hospital Pharmacies
                                                                                              1. Drug Stores & Retail Pharmacies
                                                                                                1. Online Pharmacies
                                                                                                2. U.K.
                                                                                                  1. U.K. SGLT2 Inhibitors Market, By Drug
                                                                                                    1. Canagliflozin
                                                                                                      1. Dapagliflozin
                                                                                                        1. Empagliflozin
                                                                                                          1. Ertugliflozin
                                                                                                            1. Ipragliflozin
                                                                                                              1. Sotagliflozin
                                                                                                                1. Others
                                                                                                                2. U.K. SGLT2 Inhibitors Market, By Indication
                                                                                                                  1. Type 2 Diabetes
                                                                                                                    1. Cardiovascular
                                                                                                                      1. Chronic Kidney Disease 
                                                                                                                        1. Weight Management
                                                                                                                          1. Others
                                                                                                                          2. U.K. SGLT2 Inhibitors Market, By Distribution Channel
                                                                                                                            1. Hospital Pharmacies
                                                                                                                              1. Drug Stores & Retail Pharmacies
                                                                                                                                1. Online Pharmacies
                                                                                                                              2. Germany
                                                                                                                              3. France
                                                                                                                              4. Spain
                                                                                                                              5. Italy
                                                                                                                              6. Russia
                                                                                                                              7. Nordic
                                                                                                                              8. Benelux
                                                                                                                              9. Rest of Europe
                                                                                                                            2. APAC
                                                                                                                              1. APAC SGLT2 Inhibitors Market, By Drug
                                                                                                                                1. Canagliflozin
                                                                                                                                  1. Dapagliflozin
                                                                                                                                    1. Empagliflozin
                                                                                                                                      1. Ertugliflozin
                                                                                                                                        1. Ipragliflozin
                                                                                                                                          1. Sotagliflozin
                                                                                                                                            1. Others
                                                                                                                                            2. APAC SGLT2 Inhibitors Market, By Indication
                                                                                                                                              1. Type 2 Diabetes
                                                                                                                                                1. Cardiovascular
                                                                                                                                                  1. Chronic Kidney Disease 
                                                                                                                                                    1. Weight Management
                                                                                                                                                      1. Others
                                                                                                                                                      2. APAC SGLT2 Inhibitors Market, By Distribution Channel
                                                                                                                                                        1. Hospital Pharmacies
                                                                                                                                                          1. Drug Stores & Retail Pharmacies
                                                                                                                                                            1. Online Pharmacies
                                                                                                                                                            2. China
                                                                                                                                                              1. China SGLT2 Inhibitors Market, By Drug
                                                                                                                                                                1. Canagliflozin
                                                                                                                                                                  1. Dapagliflozin
                                                                                                                                                                    1. Empagliflozin
                                                                                                                                                                      1. Ertugliflozin
                                                                                                                                                                        1. Ipragliflozin
                                                                                                                                                                          1. Sotagliflozin
                                                                                                                                                                            1. Others
                                                                                                                                                                            2. China SGLT2 Inhibitors Market, By Indication
                                                                                                                                                                              1. Type 2 Diabetes
                                                                                                                                                                                1. Cardiovascular
                                                                                                                                                                                  1. Chronic Kidney Disease 
                                                                                                                                                                                    1. Weight Management
                                                                                                                                                                                      1. Others
                                                                                                                                                                                      2. China SGLT2 Inhibitors Market, By Distribution Channel
                                                                                                                                                                                        1. Hospital Pharmacies
                                                                                                                                                                                          1. Drug Stores & Retail Pharmacies
                                                                                                                                                                                            1. Online Pharmacies
                                                                                                                                                                                          2. Korea
                                                                                                                                                                                          3. Japan
                                                                                                                                                                                          4. India
                                                                                                                                                                                          5. Australia
                                                                                                                                                                                          6. Taiwan
                                                                                                                                                                                          7. South East Asia
                                                                                                                                                                                          8. Rest of Asia-Pacific
                                                                                                                                                                                        2. Middle East and Africa
                                                                                                                                                                                          1. Middle East and Africa SGLT2 Inhibitors Market, By Drug
                                                                                                                                                                                            1. Canagliflozin
                                                                                                                                                                                              1. Dapagliflozin
                                                                                                                                                                                                1. Empagliflozin
                                                                                                                                                                                                  1. Ertugliflozin
                                                                                                                                                                                                    1. Ipragliflozin
                                                                                                                                                                                                      1. Sotagliflozin
                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                        2. Middle East and Africa SGLT2 Inhibitors Market, By Indication
                                                                                                                                                                                                          1. Type 2 Diabetes
                                                                                                                                                                                                            1. Cardiovascular
                                                                                                                                                                                                              1. Chronic Kidney Disease 
                                                                                                                                                                                                                1. Weight Management
                                                                                                                                                                                                                  1. Others
                                                                                                                                                                                                                  2. Middle East and Africa SGLT2 Inhibitors Market, By Distribution Channel
                                                                                                                                                                                                                    1. Hospital Pharmacies
                                                                                                                                                                                                                      1. Drug Stores & Retail Pharmacies
                                                                                                                                                                                                                        1. Online Pharmacies
                                                                                                                                                                                                                        2. UAE
                                                                                                                                                                                                                          1. UAE SGLT2 Inhibitors Market, By Drug
                                                                                                                                                                                                                            1. Canagliflozin
                                                                                                                                                                                                                              1. Dapagliflozin
                                                                                                                                                                                                                                1. Empagliflozin
                                                                                                                                                                                                                                  1. Ertugliflozin
                                                                                                                                                                                                                                    1. Ipragliflozin
                                                                                                                                                                                                                                      1. Sotagliflozin
                                                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                                                        2. UAE SGLT2 Inhibitors Market, By Indication
                                                                                                                                                                                                                                          1. Type 2 Diabetes
                                                                                                                                                                                                                                            1. Cardiovascular
                                                                                                                                                                                                                                              1. Chronic Kidney Disease 
                                                                                                                                                                                                                                                1. Weight Management
                                                                                                                                                                                                                                                  1. Others
                                                                                                                                                                                                                                                  2. UAE SGLT2 Inhibitors Market, By Distribution Channel
                                                                                                                                                                                                                                                    1. Hospital Pharmacies
                                                                                                                                                                                                                                                      1. Drug Stores & Retail Pharmacies
                                                                                                                                                                                                                                                        1. Online Pharmacies
                                                                                                                                                                                                                                                      2. Turkey
                                                                                                                                                                                                                                                      3. Saudi Arabia
                                                                                                                                                                                                                                                      4. South Africa
                                                                                                                                                                                                                                                      5. Egypt
                                                                                                                                                                                                                                                      6. Nigeria
                                                                                                                                                                                                                                                      7. Rest of MEA
                                                                                                                                                                                                                                                    2. LATAM
                                                                                                                                                                                                                                                      1. LATAM SGLT2 Inhibitors Market, By Drug
                                                                                                                                                                                                                                                        1. Canagliflozin
                                                                                                                                                                                                                                                          1. Dapagliflozin
                                                                                                                                                                                                                                                            1. Empagliflozin
                                                                                                                                                                                                                                                              1. Ertugliflozin
                                                                                                                                                                                                                                                                1. Ipragliflozin
                                                                                                                                                                                                                                                                  1. Sotagliflozin
                                                                                                                                                                                                                                                                    1. Others
                                                                                                                                                                                                                                                                    2. LATAM SGLT2 Inhibitors Market, By Indication
                                                                                                                                                                                                                                                                      1. Type 2 Diabetes
                                                                                                                                                                                                                                                                        1. Cardiovascular
                                                                                                                                                                                                                                                                          1. Chronic Kidney Disease 
                                                                                                                                                                                                                                                                            1. Weight Management
                                                                                                                                                                                                                                                                              1. Others
                                                                                                                                                                                                                                                                              2. LATAM SGLT2 Inhibitors Market, By Distribution Channel
                                                                                                                                                                                                                                                                                1. Hospital Pharmacies
                                                                                                                                                                                                                                                                                  1. Drug Stores & Retail Pharmacies
                                                                                                                                                                                                                                                                                    1. Online Pharmacies
                                                                                                                                                                                                                                                                                    2. Brazil
                                                                                                                                                                                                                                                                                      1. Brazil SGLT2 Inhibitors Market, By Drug
                                                                                                                                                                                                                                                                                        1. Canagliflozin
                                                                                                                                                                                                                                                                                          1. Dapagliflozin
                                                                                                                                                                                                                                                                                            1. Empagliflozin
                                                                                                                                                                                                                                                                                              1. Ertugliflozin
                                                                                                                                                                                                                                                                                                1. Ipragliflozin
                                                                                                                                                                                                                                                                                                  1. Sotagliflozin
                                                                                                                                                                                                                                                                                                    1. Others
                                                                                                                                                                                                                                                                                                    2. Brazil SGLT2 Inhibitors Market, By Indication
                                                                                                                                                                                                                                                                                                      1. Type 2 Diabetes
                                                                                                                                                                                                                                                                                                        1. Cardiovascular
                                                                                                                                                                                                                                                                                                          1. Chronic Kidney Disease 
                                                                                                                                                                                                                                                                                                            1. Weight Management
                                                                                                                                                                                                                                                                                                              1. Others
                                                                                                                                                                                                                                                                                                              2. Brazil SGLT2 Inhibitors Market, By Distribution Channel
                                                                                                                                                                                                                                                                                                                1. Hospital Pharmacies
                                                                                                                                                                                                                                                                                                                  1. Drug Stores & Retail Pharmacies
                                                                                                                                                                                                                                                                                                                    1. Online Pharmacies
                                                                                                                                                                                                                                                                                                                  2. Mexico
                                                                                                                                                                                                                                                                                                                  3. Argentina
                                                                                                                                                                                                                                                                                                                  4. Chile
                                                                                                                                                                                                                                                                                                                  5. Colombia
                                                                                                                                                                                                                                                                                                                  6. Rest of LATAM

                                                                                                                                                                                                                                                                                                              Available for purchase with detailed segment data, forecasts, and regional insights.

                                                                                                                                                                                                                                                                                                              Get This Report

                                                                                                                                                                                                                                                                                                              Download Free Sample

                                                                                                                                                                                                                                                                                                              Note: Please ensure you provide an active email address as we will be sending sample details via email.
                                                                                                                                                                                                                                                                                                              The button will be active once the above form is filled

                                                                                                                                                                                                                                                                                                              Our Clients:

                                                                                                                                                                                                                                                                                                              LG Electronics
                                                                                                                                                                                                                                                                                                              AMCAD Engineering
                                                                                                                                                                                                                                                                                                              KOBE STEEL LTD.
                                                                                                                                                                                                                                                                                                              Hindustan National Glass & Industries Limited
                                                                                                                                                                                                                                                                                                              Voith Group
                                                                                                                                                                                                                                                                                                              International Paper
                                                                                                                                                                                                                                                                                                              Hansol Paper
                                                                                                                                                                                                                                                                                                              Whirlpool Corporation
                                                                                                                                                                                                                                                                                                              Sony
                                                                                                                                                                                                                                                                                                              Samsung Electronics
                                                                                                                                                                                                                                                                                                              Qualcomm
                                                                                                                                                                                                                                                                                                              Google
                                                                                                                                                                                                                                                                                                              Fiserv
                                                                                                                                                                                                                                                                                                              Veto-Pharma
                                                                                                                                                                                                                                                                                                              Nippon Becton Dickinson
                                                                                                                                                                                                                                                                                                              Merck
                                                                                                                                                                                                                                                                                                              Argon Medical Devices
                                                                                                                                                                                                                                                                                                              Abbott
                                                                                                                                                                                                                                                                                                              Ajinomoto
                                                                                                                                                                                                                                                                                                              Denon
                                                                                                                                                                                                                                                                                                              Doosan
                                                                                                                                                                                                                                                                                                              Meiji Seika Kaisha Ltd
                                                                                                                                                                                                                                                                                                              LG Chemicals
                                                                                                                                                                                                                                                                                                              LCY chemical group
                                                                                                                                                                                                                                                                                                              Bayer
                                                                                                                                                                                                                                                                                                              Airrane
                                                                                                                                                                                                                                                                                                              BASF
                                                                                                                                                                                                                                                                                                              Toyota Industries
                                                                                                                                                                                                                                                                                                              Nissan Motors
                                                                                                                                                                                                                                                                                                              Neenah
                                                                                                                                                                                                                                                                                                              Mitsubishi
                                                                                                                                                                                                                                                                                                              Hyundai Motor Company

                                                                                                                                                                                                                                                                                                              We are featured on :

                                                                                                                                                                                                                                                                                                              WhatsApp
                                                                                                                                                                                                                                                                                                              Chat with us on WhatsApp
                                                                                                                                                                                                                                                                                                              Address:
                                                                                                                                                                                                                                                                                                              Office 515 A, Amanora Chambers,
                                                                                                                                                                                                                                                                                                              Amanora Park Town, Hadapsar,
                                                                                                                                                                                                                                                                                                              Pune 411028, Maharashtra, India.
                                                                                                                                                                                                                                                                                                              Contact Us:
                                                                                                                                                                                                                                                                                                              +1 646 905 0080 (U.S.)
                                                                                                                                                                                                                                                                                                              +91 8087085354 (India)
                                                                                                                                                                                                                                                                                                              +44 203 695 0070 (U.K.)

                                                                                                                                                                                                                                                                                                              sales@straitsresearch.com

                                                                                                                                                                                                                                                                                                              Quick Links
                                                                                                                                                                                                                                                                                                              Help
                                                                                                                                                                                                                                                                                                              Verified. Protected. Secure.
                                                                                                                                                                                                                                                                                                              DMCA.com Protection Status
                                                                                                                                                                                                                                                                                                              Secure Payments:
                                                                                                                                                                                                                                                                                                              Follow Us:
                                                                                                                                                                                                                                                                                                              www.straitsresearch.com © Copyright . All rights Reserved.